Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Latest 13D and 13G Filings > 13G Filing (0001104659-21-020146)

Filing Details

Accession Number:
0001104659-21-020146
Form Type:
13G Filing
Publication Date:
2021-02-11 06:09:53
Filed By:
Trigran Investments
Company:
Surmodics Inc (NASDAQ:SRDX)
Filing Date:
2021-02-11
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Trigran Investments, Inc 0 1,782,386 0 1,782,386 1,782,386 Approximately 13.0%
Douglas Granat 0 1,782,386 0 1,782,386 1,782,386 Approximately 13.0%
Lawrence A. Oberman 0 1,782,386 0 1,782,386 1,782,386 Approximately 13.0%
Steven G. Simon 0 1,782,386 0 1,782,386 1,782,386 Approximately 13.0%
Bradley F. Simon 0 1,782,386 0 1,782,386 1,782,386 Approximately 13.0%
Steven R. Monieson 0 1,782,386 0 1,782,386 1,782,386 Approximately 13.0%
Filing

 

 

UNITED STATES

SECURITIES AND EXCHANGE

COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

(Rule 13d-102)

 

Information Statement Pursuant to Rules 13d-1

Under the Securities Exchange Act of 1934
(Amendment No. 7)*

 

SURMODICS, INC.

(Name of Issuer)

 

Common Stock, Par Value of $0.05 Per Share

(Title of Class of Securities)

 

868873100

(CUSIP Number)

 

December 31, 2020

Date of Event Which Requires Filing of the Statement

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

x

Rule 13d-1(b)

o

Rule 13d-1(c)

¨

Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

CUSIP No. 868873100

Schedule 13G

 

 

 

1.

Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Trigran Investments, Inc.

 

 

2.

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

x

 

 

3.

SEC Use Only

 

 

 

 

4.

Citizenship or Place of Organization
Illinois corporation

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

6.

Shared Voting Power
1,782,386 shares of common stock

 

 

7.

Sole Dispositive Power
0

 

8.

Shared Dispositive Power
1,782,386 shares of common stock

 

 

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,782,386 shares of common stock (1)

 

 

 

 

10.

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
Approximately 13.0% (based on 13,676,110 shares of common stock issued and outstanding as of November 30, 2020 pursuant to the Surmodics, Inc. Form 10-K filed with the SEC on December 2, 2020)

 

 

 

 

12.

Type of Reporting Person
IA/CO

 

(1) The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of its pecuniary interest.

 

2

 

CUSIP No. 868873100

Schedule 13G

 

 

 

1.

Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Douglas Granat

 

 

 

 

2.

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

x

 

 

3.

SEC Use Only

 

 

 

 

4.

Citizenship or Place of Organization
U.S. Citizen

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

 

6.

Shared Voting Power
1,782,386 shares of common stock

 

 

7.

Sole Dispositive Power
0

 

 

8.

Shared Dispositive Power
1,782,386 shares of common stock

 

 

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,782,386 shares of common stock (1)

 

 

 

 

10.

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares  o

 

 

 

 

11.

Percent of Class Represented by Amount in Row (9)
Approximately 13.0% (based on 13,676,110 shares of common stock issued and outstanding as of November 30, 2020 pursuant to the Surmodics, Inc. Form 10-K filed with the SEC on December 2, 2020)

 

 

 

 

12.

Type of Reporting Person
IN/HC

 

(1) The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of his pecuniary interest.

 

3

 

CUSIP No. 868873100

Schedule 13G

 

 

 

1.

Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Lawrence A. Oberman

 

 

 

 

2.

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

x

 

 

3.

SEC Use Only

 

 

 

 

4.

Citizenship or Place of Organization
U.S. Citizen

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

 

6.

Shared Voting Power
1,782,386 shares of common stock

 

 

7.

Sole Dispositive Power
0

 

 

8.

Shared Dispositive Power
1,782,386 shares of common stock

 

 

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,782,386 shares of common stock (1)

 

 

 

 

10.

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares  o

 

 

 

 

11.

Percent of Class Represented by Amount in Row (9)
Approximately 13.0% (based on 13,676,110 shares of common stock issued and outstanding as of November 30, 2020 pursuant to the Surmodics, Inc. Form 10-K filed with the SEC on December 2, 2020)

 

 

 

 

12.

Type of Reporting Person
IN/HC

 

(1) The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of his pecuniary interest.

 

4

 

CUSIP No. 868873100

Schedule 13G

 

 

 

1.

Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Steven G. Simon

 

 

 

 

2.

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

x

 

 

3.

SEC Use Only

 

 

 

 

4.

Citizenship or Place of Organization
U.S. Citizen

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

 

6.

Shared Voting Power
1,782,386 shares of common stock

 

 

7.

Sole Dispositive Power
0

 

 

8.

Shared Dispositive Power
1,782,386 shares of common stock

 

 

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,782,386 shares of common stock (1)

 

 

 

 

10.

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares  o

 

 

 

 

11.

Percent of Class Represented by Amount in Row (9)
Approximately 13.0% (based on 13,676,110 shares of common stock issued and outstanding as of November 30, 2020 pursuant to the Surmodics, Inc. Form 10-K filed with the SEC on December 2, 2020)

 

 

 

 

12.

Type of Reporting Person
IN/HC

 

(1) The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of his pecuniary interest.

 

5

 

CUSIP No. 868873100

Schedule 13G

 

 

 

1.

Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Bradley F. Simon

 

 

 

 

2.

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

x

 

 

3.

SEC Use Only

 

 

 

 

4.

Citizenship or Place of Organization
U.S. Citizen

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

 

6.

Shared Voting Power
1,782,386 shares of common stock

 

 

7.

Sole Dispositive Power
0

 

 

8.

Shared Dispositive Power
1,782,386 shares of common stock

 

 

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,782,386 shares of common stock (1)

 

 

 

 

10.

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares  o

 

 

 

 

11.

Percent of Class Represented by Amount in Row (9)
Approximately 13.0% (based on 13,676,110 shares of common stock issued and outstanding as of November 30, 2020 pursuant to the Surmodics, Inc. Form 10-K filed with the SEC on December 2, 2020)

 

 

 

 

12.

Type of Reporting Person
IN/HC

 

(1) The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of his pecuniary interest.

 

6

 

CUSIP No. 868873100

Schedule 13G

 

 

 

1.

Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Steven R. Monieson

 

 

 

 

2.

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

x

 

 

3.

SEC Use Only

 

 

 

 

4.

Citizenship or Place of Organization
U.S. Citizen

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

 

6.

Shared Voting Power
1,782,386 shares of common stock

 

 

7.

Sole Dispositive Power
0

 

 

8.

Shared Dispositive Power
1,782,386 shares of common stock

 

 

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,782,386 shares of common stock (1)

 

 

 

 

10.

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares  o

 

 

 

 

11.

Percent of Class Represented by Amount in Row (9)
Approximately 13.0% (based on 13,676,110 shares of common stock issued and outstanding as of November 30, 2020 pursuant to the Surmodics, Inc. Form 10-K filed with the SEC on December 2, 2020)

 

 

 

 

12.

Type of Reporting Person
IN/HC

 

(1) The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of his pecuniary interest.

 

7

 

CUSIP No. 868873100

Schedule 13G

 

 

Item 1(a)

Name of Issuer:
Surmodics, Inc.

Item 1(b)

Address of Issuers Principal Executive Offices:

9924 West 74th Street

Eden Prairie, Minnesota 55344

 

Item 2(a)

Name of Person Filing
See Item 2(c)

Item 2(b)

Address of Principal Business Office
See Item 2(c)

Item 2(c)

Citizenship
Trigran Investments, Inc.

630 Dundee Road, Suite 230

Northbrook, IL 60062

Illinois corporation

 

Douglas Granat

630 Dundee Road, Suite 230

Northbrook, IL 60062

U.S. Citizen

 

Lawrence A. Oberman

630 Dundee Road, Suite 230

Northbrook, IL 60062

U.S. Citizen

 

Steven G. Simon

630 Dundee Road, Suite 230

Northbrook, IL 60062

U.S. Citizen

 

Bradley F. Simon

630 Dundee Road, Suite 230

Northbrook, Illinois 60062

U.S. Citizen

 

Steven R. Monieson

630 Dundee Road, Suite 230

Northbrook, Illinois 60062

U.S. Citizen

Item 2(d)

Title of Class of Securities:
Common Stock, par value of $0.05 per share

Item 2(e)

CUSIP Number:
868873100

 

Item 3

If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

 

(a)

o

Broker or dealer registered under section 15 of the Exchange Act;

 

(b)

o

Bank as defined in section 3(a)(6) of the Exchange Act;

 

8

 

CUSIP No. 868873100

Schedule 13G

 

 

 

(c)

o

Insurance company as defined in section 3(a)(19) of the Exchange Act;

 

(d)

o

Investment company registered under section 8 of the Investment Company Act;

 

(e)

x

An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

 

(f)

o

An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

 

(g)

x

A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

 

(h)

o

A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

 

(i)

o

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act;

 

(j)

o

A non-U.S. institution in accordance with Rule 13d1(b)(1)(ii)(J);

 

(k)

o

Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d1(b)(1)(ii)(J), please specify the type of institution:                      

If this statement is filed pursuant to Rule 13d-1(c), check this box. o

 

Item 4

Ownership:(2)

 

(a)

Amount beneficially owned:

Incorporated by reference to Item 9 of the cover page pertaining to each reporting person.

 

(b)

Percent of class:

Incorporated by reference to Item 11 of the cover page pertaining to each reporting person.

 

(c)

Number of shares as to which such person has:

 

 

 

(i)

Sole power to vote or to direct the vote:

Incorporated by reference to Item 5 of the cover page pertaining to each reporting person.

 

 

(ii)

Shared power to vote or to direct the vote:

Incorporated by reference to Item 6 of the cover page pertaining to each reporting person.

 

 

(iii)

Sole power to dispose or to direct the disposition of:

Incorporated by reference to Item 7 of the cover page pertaining to each reporting person.

 

 

(iv)

Shared power to dispose or to direct the disposition of:

Incorporated by reference to Item 8 of the cover page pertaining to each reporting person.

 

(2)  Douglas Granat, Lawrence A. Oberman, Steven G. Simon, Bradley F. Simon, and Steven R. Monieson are the controlling shareholders and officers of Trigran Investments, Inc. and thus may be considered the beneficial owners of shares beneficially owned by Trigran Investments, Inc.

 

9

 

CUSIP No. 868873100

Schedule 13G

 

 

Item 5

Ownership of Five Percent or Less of a Class:

 

Not Applicable.

 

Item 6

Ownership of More than Five Percent on Behalf of Another Person:

Owners of accounts managed by Trigran Investments, Inc. have or may have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, securities held in their accounts.  No such account has such power with respect to more than five percent of the class of securities to which this Schedule 13G relates.

 

Item 7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:

 

Not Applicable.

 

Item 8

Identification and Classification of Members of the Group:

 

Not Applicable.

 

Item 9

Notice of Dissolution of Group:

 

Not Applicable.

 

Item 10

Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

10

 

CUSIP No. 868873100

Schedule 13G

 

 

After reasonable inquiry and to the best of its knowledge and belief, the undersigned Reporting Persons certify that the information set forth in this statement is true, complete, and correct.

 

Date: February 11, 2021

 

 

TRIGRAN INVESTMENTS, INC.

 

 

 

 

By:

/s/ Lawrence A. Oberman

 

Name:

Lawrence A. Oberman

 

Title:

Executive Vice President

 

 

 

 

 

/s/ Douglas Granat

 

Douglas Granat

 

 

 

 

 

/s/ Lawrence A. Oberman

 

Lawrence A. Oberman

 

 

 

 

 

/s/ Steven G. Simon

 

Steven G. Simon

 

 

 

 

 

/s/ Bradley F. Simon

 

Bradley F. Simon

 

 

 

 

 

/s/ Steven R. Monieson

 

Steven R. Monieson

 

 

11

 

CUSIP No. 868873100

Schedule 13G

 

 

INDEX TO EXHIBITS

 

 

 

PAGE

 

 

 

EXHIBIT 1: Agreement to Make a Joint Filing

 

1

 

12